CONMED Corporation (CNMD)
$45.55+0.42%Close
SELLRECOVERY · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.4B
- Beta
- 0.94
- Div yield
- 0.44%
- P/E (TTM)
- 24.59
- Short % float
- 6.56%
- Days to cover
- 5.2
- SI change
- -8.5%
- 1W
- +2.41%
- 1M
- -1.79%
- vs SPY 1W
- +2.54%
- vs SPY 1M
- -4.30%
Industry peers
FMP comparable companies · ranked by market cap
- NEOGSELLNeogen Corporation$2.6BBEARQ 16$12.00-2.25%
- UFPTBUYUFP Technologies, Inc.$2.3BRECOVERYQ 23$295.82-0.52%
- ESTASELLEstablishment Labs Holdings Inc.$1.8BCRISISQ 15$61.63-5.16%
- NTLABUYIntellia Therapeutics, Inc.$1.8BRECOVERYQ 3$12.58-5.33%
- AZTABUYAzenta, Inc.$1.7BRECOVERYQ 9$37.77+0.26%
- NVCRSELLNovocure Ltd$1.7BCRISISQ 11$14.72-2.85%
- KMTSBUYKestra Medical Technologies, Ltd.$1.6BBEARQ 23$26.91+0.22%
- AHCOBUYAdaptHealth Corp.$835MRECOVERYQ 0$6.14+3.09%
- INMDSELLInMode Ltd.$822MBEARQ 15$14.30+0.07%
- SSIISELLSS Innovations International, Inc.$510MCRISISQ 15$2.55+0.00%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CNMD?
- LOPJLB’s latest quantitative signal on CONMED Corporation (CNMD) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is CNMD in?
- CONMED Corporation (CNMD) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does CONMED Corporation (CNMD) do?
- CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Ancho…